BMY's plunge, an omen for other cancer drug stocks?
June 01, 2015 at 05:00 AM EDT
The 6 percent drop in Bristol-Myers Squibb shares Friday could be a taste of things to come for biotech and pharmaceuticals stocks this week as ASCO continues in Chicago.
